Lovastatin
FDA Label NDC 50090-3216

53 label sections · Submitted to the FDA by A-s Medication Solutions · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by A-s Medication Solutions for the product Lovastatin (NDC 50090-3216). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding description, clinical pharmacology, clinical studies in adults, expanded clinical evaluation of lovastatin (excel) study, air force/texas coronary atherosclerosis prevention study (afcaps/texcaps), atherosclerosis, eye, efficacy of lovastatin in adolescent boys with heterozygous familial hypercholesterolemia, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Label Section Quick Index

Storage

Store at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature]. Lovastatin Tablets USP must be protected from light. Dispense in a tight, light-resistant container as defined in the USP, with a child-resistant closure (as required). KEEP THIS AND ALL MEDICATIONS OUT OF THE REACH OF CHILDREN. Manufactured In Croatia By: PLIVA HRVATSKA d.o.o. Zagreb, Croatia

* Please review the disclaimer below.